变量 | 例数N/% | ||
年龄 |
| ||
>50 | 70 (50.0) | ||
≤50 | 70 (50.0) | ||
月经 |
| ||
绝经前 | 62 (44.3) | ||
绝经后 | 78 (55.7) | ||
病理类型 |
| ||
浸润性癌 | 133 (95.0) | ||
其余 | 7 (5.0) | ||
组织学分级 |
| ||
G1~G2 | 96 (68.6) | ||
G3 | 44 (31.4) | ||
淋巴结情况 |
| ||
阴性 | 68 (48.6) | ||
阳性 | 72 (51.4) | ||
临床分期 |
| ||
Ⅰ~Ⅱ期 | 91 (65.0) | ||
Ⅲ期 | 49 (35.0) | ||
激素受体 |
| ||
阳性 | 89 (63.6) | ||
阴性 | 51 (36.4) | ||
HER-2 |
| ||
阳性 | 33 (23.6) | ||
阴性 | 107 (76.4) | ||
分型 |
| ||
Luminal A | 51 (36.4) | ||
Luminal B | 27 (19.3) | ||
HER-2阳性 | 31 (22.1) | ||
三阴性 | 31 (22.1) | ||
Kit-67 |
| ||
≤14% | 45 (32.1) | ||
>14% | 195 (67.9) | ||
化疗方案 |
| ||
蒽环 | 96 (68.6) | ||
去蒽环 | 44 (31.4) | ||
MP分级 |
| ||
1 | 7 (5) | ||
2 | 40 (28.6) | ||
3 | 58 (41.4) | ||
4 | 14 (10.0) | ||
5 | 21 (15.0) | ||
PCR |
| ||
是 | 21 (15.0) | ||
否 | 119 (85.0) | ||
TILs |
| ||
≤25% | 110 (78.6) | ||
>25% | 30 (21.4) | ||